Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Shattuck Labs, Inc.
University of Nebraska
Hackensack Meridian Health
University of California, Irvine
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Orca Biosystems, Inc.
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Gamida Cell ltd
City of Hope Medical Center
Celgene
Dartmouth-Hitchcock Medical Center
Bristol-Myers Squibb
Astellas Pharma Inc
Hutchmed
NextCure, Inc.
University of Colorado, Denver
National Cancer Institute (NCI)
University of Rochester
Chang Gung University
Brown University
Novartis
Vanderbilt-Ingram Cancer Center
Masonic Cancer Center, University of Minnesota
Astellas Pharma Inc
Montefiore Medical Center
M.D. Anderson Cancer Center